Dutasteride is the strongest available drug for shutting down the conversion of testosterone to DHT, the hormone that drives male and female pattern hair loss, prostate enlargement, and frontal fibrosing alopecia. It was originally developed and approved for benign prostatic hyperplasia (BPH), where it shrinks an enlarged prostate over time. Most people now take it off-label at the same 0.5 mg daily dose for hair loss, where it consistently outperforms finasteride in head-to-head trials.

Finasteride blocks one of the two 5-alpha-reductase enzymes and drops blood DHT by around 70%. Dutasteride blocks both and drops it by around 95%. In practice that translates to more hair regrown, more thinning halted, and a much longer drug half-life (around 5 weeks) so missed doses don't matter much. The trade is that the same DHT suppression that protects your hair also affects libido, mood, and ejaculation volume in a meaningful minority of users, and the long half-life means side effects, when they happen, take longer to clear. This is a serious drug, not a supplement, and the decision to start it should be made with a clear-eyed view of both sides.

Deep-dive

Dosage:

• Standard dose for hair loss: 0.5 mg daily, oral, the same dose used in BPH. This is the dose with the most evidence behind it and the one approved in Korea, Japan, and Taiwan for AGA. Once steady-state is reached (around 3-6 months), many users move to every other day or 2-3 times weekly with similar DHT suppression, taking advantage of the 5-week half-life. There's no clean RCT comparing daily to intermittent dosing in men long-term, but the pilot data on twice and thrice weekly dosing showed comparable hair count gains to daily finasteride
• Standard dose for BPH: 0.5 mg daily. Same capsule, same molecule, just framed around a different indication. Effect on prostate volume builds over months and is maintained as long as treatment continues
• Women (post-menopausal or on reliable contraception): 0.15-0.5 mg daily for female pattern hair loss, often started at the lower end or at twice-weekly dosing. For frontal fibrosing alopecia, 0.5 mg daily is the typical starting dose, sometimes reduced to once weekly for maintenance. Pre-menopausal women without reliable contraception should not use oral dutasteride at all
• Topical: 0.01-0.05% solution applied once daily to the scalp, typically in an ethanol/PG vehicle. The 0.05% concentration showed the strongest hair count effect in the Phase II trial with very low systemic exposure. Quality of compounded topical varies, prefer pharmacies with HPLC purity testing
• Mesotherapy: 0.01% dutasteride injected intradermally into the scalp at monthly to quarterly intervals by a trained clinician. This is in-clinic only, not for self-administration
• Timing: Take orally with or without food, the absorption is unaffected by meals. Timing of day doesn't matter given the long half-life. Consistency matters more than timing
• Stopping: DHT returns to baseline over roughly 4-6 months as the drug clears. Hair benefits typically reverse over 6-12 months. This is not a drug you stop and start casually, the long washout means side effects, if any, also take a while to fully resolve

Here's what you can expect:

The first 3-6 months you'll see very little visible change, and you may even shed more in the first few weeks as follicles cycle from telogen back into anagen. By month 6, hair on top of the head looks thicker in consistent-lighting photos, and shedding rates drop. By month 12, regrowth in previously thinned areas is usually visible. Peak hair count gains typically arrive at 12-24 months and are maintained with continued use. If you've crossed into significant Norwood 5 or 6 territory, expect maintenance and partial thickening rather than full reversal. The follicle has to still be alive to come back.

For BPH, urinary symptoms (frequency, urgency, weak stream) usually start improving by month 3 and reach plateau by month 12. Prostate volume reduction is gradual and reaches around 25% by 2 years.

If you experience sexual side effects, they usually appear within the first 1-3 months. For most users they're mild and fade with continued use as the body adapts. For a minority they persist and require dose reduction or discontinuation. Watch the first 90 days closely.

Side effects & risks:

• Sexual side effects (reduced libido, erectile dysfunction, reduced ejaculate volume) are the most common and most clinically relevant issue. Reported rates in the 0.5 mg dutasteride trials sit in the 4-7% range, broadly similar to finasteride 1 mg per pooled meta-analyses, despite the deeper DHT suppression. Most reverse on discontinuation within weeks to months as the drug clears